1. Home
  2. MRBK vs SGMO Comparison

MRBK vs SGMO Comparison

Compare MRBK & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRBK
  • SGMO
  • Stock Information
  • Founded
  • MRBK 2004
  • SGMO 1995
  • Country
  • MRBK United States
  • SGMO United States
  • Employees
  • MRBK N/A
  • SGMO N/A
  • Industry
  • MRBK Major Banks
  • SGMO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • MRBK Finance
  • SGMO Health Care
  • Exchange
  • MRBK Nasdaq
  • SGMO Nasdaq
  • Market Cap
  • MRBK 191.0M
  • SGMO 180.5M
  • IPO Year
  • MRBK 2017
  • SGMO 2000
  • Fundamental
  • Price
  • MRBK $14.20
  • SGMO $2.51
  • Analyst Decision
  • MRBK Buy
  • SGMO Buy
  • Analyst Count
  • MRBK 2
  • SGMO 3
  • Target Price
  • MRBK $16.00
  • SGMO $7.00
  • AVG Volume (30 Days)
  • MRBK 25.5K
  • SGMO 7.3M
  • Earning Date
  • MRBK 01-24-2025
  • SGMO 11-12-2024
  • Dividend Yield
  • MRBK 3.53%
  • SGMO N/A
  • EPS Growth
  • MRBK N/A
  • SGMO N/A
  • EPS
  • MRBK 1.00
  • SGMO N/A
  • Revenue
  • MRBK $92,357,000.00
  • SGMO $52,291,000.00
  • Revenue This Year
  • MRBK N/A
  • SGMO N/A
  • Revenue Next Year
  • MRBK $11.13
  • SGMO $9.31
  • P/E Ratio
  • MRBK $14.10
  • SGMO N/A
  • Revenue Growth
  • MRBK N/A
  • SGMO N/A
  • 52 Week Low
  • MRBK $8.26
  • SGMO $0.30
  • 52 Week High
  • MRBK $17.33
  • SGMO $3.18
  • Technical
  • Relative Strength Index (RSI)
  • MRBK 35.78
  • SGMO 55.54
  • Support Level
  • MRBK $15.37
  • SGMO $2.24
  • Resistance Level
  • MRBK $17.17
  • SGMO $2.82
  • Average True Range (ATR)
  • MRBK 0.38
  • SGMO 0.28
  • MACD
  • MRBK -0.34
  • SGMO 0.02
  • Stochastic Oscillator
  • MRBK 4.07
  • SGMO 52.88

About MRBK Meridian Corporation

Meridian Corp is a full-service, state-chartered commercial bank providing personal, business lending, and deposit services. It operates in three business segments including Bank, Wealth, and Mortgage. It generates maximum revenue from the Bank segment that consists of commercial and retail banking. It generates interest income from its lending (including leasing) and investing activities and is dependent on the gathering of lower-cost deposits from its branch network or borrowed funds from other sources for funding its loans, resulting in the generation of net interest income, and other sources.

About SGMO Sangamo Therapeutics Inc.

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.

Share on Social Networks: